SavedAdd your journal

Journals / Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi / 2020 / Cilt: 15 Sayı: 1

ASSOCIATION BETWEEN METABOLIC SYNDROME AND ERECTILE DYSFUNCTION

METABOLİK SENDROM VE EREKTİL DİSFONKSİYON İLİŞKİSİ

Murat ŞAHİN
Pages
58–63
Publication Date
2020-03-26
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Both erectile dysfunction and metabolic syndrome share common risk factors that cause endothelial dysfunction and atherosclerosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Metabolic syndrome is a metabolic dysregulation characterized by insülin resistance, hyperinsulinemia, hypertension, obesity, and dyslipidemia.
📊
Key Findings & Data:Erectile dysfunction is defined as the persistent inability to achieve and maintain erection to perform successful sexual intercourse.
💡
Conclusion & Impact:Both erectile dysfunction and metabolic syndrome share common risk factors that cause endothelial dysfunction and atherosclerosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:metabolik sendrom · erektil disfonksiyon · metabolic syndrome

Abstract

Metabolic syndrome is a metabolic dysregulation characterized by insülin resistance, hyperinsulinemia, hypertension, obesity, and dyslipidemia. Erectile dysfunction is defined as the persistent inability to achieve and maintain erection to perform successful sexual intercourse. Both erectile dysfunction and metabolic syndrome share common risk factors that cause endothelial dysfunction and atherosclerosis.

Özet

Metabolik sendrom insülin direnci, hiperinsülinemi, hipertansiyon, obezite ve dislipidemi ile karakterize bir metabolik bozukluktur. Erektil disfonksiyon başarılı bir cinsel ilişki sağlamak için ereksiyonun başlatılamaması yada sürdürülememesi olarak tanımlanmaktadır. Hem erektil disfonksiyon hem metabolik sendrom endotelyal disfonksiyon ve ateroskleroza yol açan ortak risk faktörlerine sahiptirler.

🔖

Cite This Article

ŞAHİN, M. (2020). ASSOCIATION BETWEEN METABOLIC SYNDROME AND ERECTILE DYSFUNCTION. Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi, Cilt: 15 Sayı: 1, 58–63. https://ajindex.com/articles/908430

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination Survey. J Am Med Assoc. 2002;287(3):356–9
  2. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care. 2004;27(10):2444–9
  3. Abacı A, Kılıçkap M, Göksülük H, Karaaslan D, Barçın C, Kayıkçıoğlu M, et al. Data on prevalence of metabolic syndrome in Turkey: Systematic review, meta-analysis and meta-regression of epidemiological studies on cardiovascular risk factors. Turk Kardiyol Dern Arsivi-Archives Turkish Soc Cardiol [Internet]. 2018 [cited 2019 Jun 20];46(7):591–601. Available from: http://www.ncbi.nlm.nih.gov/pubmed/303919884. Engin A. The Pathogenesis of Obesity-Associated Adipose Tissue Inflammation. In: Advances in experimental medicine and biology [Internet]. 2017 [cited 2019 Jun 20]. p. 221–45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/285852015. Swaroop JJ, Rajarajeswari D, Naidu JN. Association of TNF-α with insulin resistance in type 2 diabetes mellitus. Indian J Med Res. 2012;135(1):127–30
  4. Li Y, Zhong X, Cheng G, Zhao C, Zhang L, Hong Y, et al. Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis. Atherosclerosis [Internet]. 2017 Apr [cited 2019 Jun 20];259:75–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/283274517. Rehman K, Akash MSH, Liaqat A, Kamal S, Qadir MI, Rasul A. Role of Interleukin-6 in Development of Insulin Resistance and Type 2 Diabetes Mellitus. Crit Rev Eukaryot Gene Expr [Internet]. 2017 [cited 2019 Jun 20];27(3):229–36. Available from: http://www.ncbi.nlm.nih.gov/pubmed/291996088. Del Giudice M, Gangestad SW. Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters. Brain Behav Immun [Internet]. 2018 May [cited 2019 Jun 20];70:61–75. Available from: http://www.ncbi.nlm.nih.gov/pubmed/294993029. Jung RG, Motazedian P, Ramirez FD, Simard T, Di Santo P, Visintini S, et al. Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis. Thromb J [Internet]. 2018 [cited 2019 Jun 20];16:12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2999192610. Gruzdeva O, Borodkina D, Uchasova E, Dyleva Y, Barbarash O. Leptin resistance: underlying mechanisms and diagnosis. Diabetes Metab Syndr Obes [Internet]. 2019 [cited 2019 Jun 20];12:191–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3